FDA authorizes one-shot coronavirus vaccine from Johnson & Johnson The Food and Drug Administration on Saturday authorized a coronavirus vaccine developed by Johnson & Johnson, clearing emergency use of the shot at a critical moment for U.S. efforts to control COVID-19. Only a few million doses will be immediately available to ship, but J&J expects to deliver 20 million by the end of March and 100 million by the end of June — much-needed reinforcements as vaccine supplies from Pfizer and Moderna remain limited. |
No comments:
Post a Comment